Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-25-104050
Filing Date
2025-04-29
Accepted
2025-04-29 17:14:44
Documents
19
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d574678d10ka.htm   iXBRL 10-K/A 541372
2 EX-31.1 d574678dex311.htm EX-31.1 6771
3 EX-31.2 d574678dex312.htm EX-31.2 6762
  Complete submission text file 0001193125-25-104050.txt   952679

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA orgo-20241231.xsd EX-101.SCH 5585
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE orgo-20241231_def.xml EX-101.DEF 16705
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE orgo-20241231_lab.xml EX-101.LAB 22692
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE orgo-20241231_pre.xml EX-101.PRE 18206
22 EXTRACTED XBRL INSTANCE DOCUMENT d574678d10ka_htm.xml XML 12816
Mailing Address 85 DAN ROAD CANTON MA 02021
Business Address 85 DAN ROAD CANTON MA 02021 781-575-0775
Organogenesis Holdings Inc. (Filer) CIK: 0001661181 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-37906 | Film No.: 25889447
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)